We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Rebecca E. Dombrowski
Rebecca E. Dombrowski
Products
PRODUCTS
Pharmacia & Upjohn Co., LLC
Thomas J. Cosgrove
,
Rebecca E. Dombrowski
,
Andrew J. Idzior
, and
Jeffrey D. Meng
Price:
$117.00
View
Pfizer, Inc.
Rebecca E. Dombrowski
and
Emily J. Orban
Price:
$117.00
View
L. Perrigo Co.
Rebecca E. Dombrowski
,
Geneve M. Maxwell
,
Cheryl M. Monroe
, and
Martha Sullivan Myrick
Price:
$117.00
View
Spectron MRC, LLC
Rebecca E. Dombrowski
Price:
$117.00
View
Grand River Aseptic Manufacturing, Inc.
Rebecca E. Dombrowski
Price:
$117.00
View
Amri Burlington, Inc.
Rebecca E. Dombrowski
and
Abdur-Rafay Shareef
Price:
$117.00
View
Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH
Rebecca E. Dombrowski
Price:
$117.00
View
Baxter Pharmaceutical Solutions, LLC
Rebecca E. Dombrowski
,
Andrew J. Idzior
,
Jeffrey D. Meng
,
Sarah M. Napier
, and
Cheng H. Yen
Price:
$117.00
View
JHP Pharmaceuticals, LLC
Rebecca E. Dombrowski
and
Sarah M. Napier
Price:
$117.00
View
Amgen Manufacturing Ltd., Inc.
Rebecca E. Dombrowski
and
Jose R. Lopez
Price:
$117.00
View
View All Products by Rebecca E. Dombrowski
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Kroger’s COVID-19 Test Home Collection Kit Cleared for Emergency Use
Pfizer and BioNTech Report Positive Results from COVID-19 Vaccine Trial
EUSA Pharma to Begin Phase 3 Trial of Siltuximab for COVID-19 in U.S.
FDA Issues Emergency Use Authorization for Centogene’s COVID-19 Assay
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
